Recombinant Human TBK1 Protein，His

TBK1 (TANK-binding kinase 1) is a serine/threonine kinase that plays a crucial role in various cellular processes, including immune response, inflammation, and cellular homeostasis. It is involved in the activation of the NF-κB signaling pathway, which is essential for regulating immune responses and inflammatory processes. Recent studies have highlighted the significance of TBK1 in neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), where mutations in the TBK1 gene contribute to disease pathogenesis. The investigation of TBK1 recombinant proteins has become increasingly important for understanding its functional mechanisms and developing potential therapeutic strategies. By producing TBK1 in a recombinant system, researchers can study its biochemical properties, interaction with various substrates, and its role in cellular signaling pathways. Understanding the structure and function of TBK1 at the molecular level through recombinant protein studies could provide insights into the development of targeted therapies for diseases associated with TBK1 dysfunction. Moreover, exploring the pharmacological modulation of TBK1 activity may open new avenues for treating inflammatory and neurodegenerative disorders, highlighting the protein's potential as a therapeutic target. Overall, TBK1 recombinant protein research aims to unravel the complexities of its biological functions and therapeutic implications, contributing to our understanding of disease mechanisms and treatment options.